Perimenopause Anxiety: Sometimes It’s a Progesterone Deficiency
Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.
Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.
In this episode, we’re joined by Claire Love, deals strategy principal at PwC. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market.
While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: gender meaningfully influences how substance use develops, how it is experienced, and what supports effective treatment.
Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the difference between life and death for women.
Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains.
In this episode, we’re joined by Cheryl Larson, president and CEO of the Midwest Business Group on Health, for our first in-person recording at MedCity News’ recent Bullseye event.
Juno Bio’s funding was supported by Ada Ventures, Artesian, Entrepreneur First and Illumina Accelerator.
For someone already managing chronic disease, menopause can disrupt stability and complicate treatment plans in ways that aren’t always immediately visible but show up over time in outcomes and utilization.
Testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.”
While the Pap identifies the cell changes, the HPV test determines the root cause before those changes even happen. Both tests have saved lives. But they are not interchangeable, and treating them as such puts the patient at risk.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob.
The issue is not only functional. It is experiential. Many women do not need more scores. They need continuity, context, and support that feels companionable rather than corrective.
Winona launched a new research initiative to fund and support menopause and women's health research.
Capital is flowing into the broader women’s health ecosystem at a pace we have not seen before. The practices that will capture value from that momentum are the ones that get their operational house in order now.
Innovation in women’s health technology is about improving input data, refining performance criteria and ensuring design assumptions align with biological reality and real-world usage. When those fundamentals are in place, products are more accurate, more trustworthy and more likely to be adopted by clinicians and consumers alike.